# SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance

Xavier Montagutelli, Sylvie van der Werf, Felix A Rey, Etienne Simon-loriere

► To cite this version:

Xavier Montagutelli, Sylvie van der Werf, Felix A Rey, Etienne Simon-loriere. SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance. EMBO Molecular Medicine, 2022, 14 (3), pp.e15558. 10.15252/emmm.202115558. pasteur-03695443

HAL Id: pasteur-03695443

https://pasteur.hal.science/pasteur-03695443

Submitted on 14 Jun 2022

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

<figure><img src="image_3.png" /></figure>

# SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance

Xavier Montagutelli<fnref n="1" />,*, Sylvie van der Werf<fnref n="2" />,<fnref n="3" /> ID, Felix A Rey<fnref n="4" /> ID & Etienne Simon-Loriere<fnref n="5" />,** ID

Throughout its short history, SARS-CoV-2 has demonstrated its capacity to jump back and forth between humans and animals. Following its emergence from a likely bat reservoir, with or without an intermediate host, the virus has successfully infected an array of domestic and wild animals (Chandler *et al*, 2021; OIE, 2022). In 2020, the infection of mink farms in multiple countries was a strong reminder of the importance of One-Health surveillance. The constitution of a non-human reservoir from where the virus could spill back into humans is a major concern, as exemplified by multiple viruses, including influenza, with documented cases of human-to-swine-to-human transmission (Glud *et al*, 2021). Importantly, the intensive circulation of an emerging virus in a new host leads to the accumulation of amino acid changes, some reflecting adaptation to this novel environment, which could result in the evolution of variants with unpredictable properties with regard to human infection. As a case in point, SARS-CoV-2 spillback from minks to humans in Denmark was associated with lower capability of pre-existing human antibodies to neutralize the variant (Larsen *et al*, 2021).

Living close to humans, sometimes in large numbers, rodents are susceptible to infectious diseases that can threaten human health, such as plague, leptospirosis, or Lassa fever. In March 2021, we reported that mice, which are not susceptible to the initial SARS-CoV-2 genotype, were permissive to viral replication of the Alpha, Beta, and

Gamma Variants of Concern (VOC; preprint: Montagutelli *et al*, 2021b), a finding that was later confirmed by others. We also demonstrated that Beta could be transmitted between mice by direct contact (preprint: Montagutelli *et al*, 2021b). Central to this host range expansion is the N501Y substitution in the receptor-binding domain of the spike, a convergent change detected in many SARS-CoV-2 lineages.

The newly emerged Omicron VOC harbors not only N501Y but also changes at residues 493 and 498 to basic amino acids as seen recurrently in mouse-adapted strains (Fig 1), arguing for its capacity to replicate in mice. The intense circulation of variants presenting these features is a stark warning of the risk of reservoirs of SARS-CoV-2 in wild rodents, and this risk could extend to other animal species with sufficient population densities. In fact, the genomic variations of Omicron are so extensive that they could have been acquired upon circulation in an animal reservoir, a credible alternative hypothesis for its emergence process.

We thus call for practical reinforcements of collaborative efforts of surveillance at the human-animal interface and its environment—both in high-density cities and rural places for rodents—as a critical determinant of current and future pandemic risk.

**Expanded View** for this article is available online.

## Acknowledgments

This work was supported by the "URGENCE COVID-19" fundraising campaign of Institut

Pasteur), the French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (Grant No. ANR-10-LABX-62-IBEID), the Agence Nationale de la Recherche (Grant No. ANR-20-COVI-0028-01) and the RECOVER project funded by the European Union's Horizon 2020 research and innovation program under grant agreement No. 101003589. ESL acknowledges funding from the INCEPTION program (Investissements d'Avenir grant ANR-16-CONV-0005).

## Author contributions

XM and ES-L designed and coordinated the study. FAR performed structural analysis. XM and ES-L wrote and revised the manuscript with input from SW and FAR.

## References

* Chandler JC, Bevins SN, Ellis JW, Linder TJ, Tell RM, Jenkins-Moore M, Root JJ, Lenoch JB, Robbe-Austerman S, DeLiberto TJ *et al* (2021) SARS-CoV-2 exposure in wild white-tailed deer (*Odocoileus virginianus*). *Proc Natl Acad Sci USA* 118: e2114828118

* Glud HA, George S, Skovgaard K, Larsen LE (2021) Zoonotic and reverse zoonotic transmission of viruses between humans and pigs. *APMIS* 129: 675–693

* Huang K, Zhang Y, Hui X, Zhao YA, Gong W, Wang T, Zhang S, Yang Y, Deng F, Zhang Q *et al* (2021) Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice. *EBioMedicine* 67: 103381

* Larsen HD, Fonager J, Lomholt FK, Dalby T, Benedetti G, Kristensen B, Urth TR, Rasmussen M, Lassauniere R, Rasmussen

<footnote n="1">1 Mouse Genetics Laboratory, Institut Pasteur, Université de Paris, Paris, France</footnote>

<footnote n="2">2 Molecular Genetics of RNA Viruses Unit, CNRS UMR 3569, Institut Pasteur, Université de Paris, Paris, France</footnote>

<footnote n="3">3 National Reference Center for Respiratory Viruses, Institut Pasteur, Université de Paris, Paris, France</footnote>

<footnote n="4">4 Structural Virology Unit, CNRS UMR 3569, Institut Pasteur, Université de Paris, Paris, France</footnote>

<footnote n="5">5 G5 Evolutionary Genomics of RNA Viruses, Institut Pasteur, Université de Paris, Paris, France
*Corresponding author. E-mail: xavier.montagutelli@pasteur.fr</footnote>

<footnote>**Corresponding author. E-mail: etienne.simon-loriere@pasteur.fr</footnote>
<figure><img src="image_4.png" /><figcaption>**Figure 1.** Amino acid changes in the receptor-binding domain (RBD) of the spike of SARS-CoV-2.</figcaption></figure>

Residues 417, 493, 498, and 501 are also modified in several mouse-adapted SARS-CoV-2 strains. A: Table of changes in section of the RBD for pandemic lineages and mouse-adapted strains. B: Mapping onto the X-ray structure of the RBD (PDB 6M0J) shown as a white surface with the human ACE2 contact area highlighted in yellow (left panels). The RBD residues recurrently observed as undergoing changes upon adaptation of SARS-CoV-2 to mice are marked in blue in the middle panels, while the multiple changes observed in the RBD of the Omicron variant spike are indicated in purple in the right panels. Mouse-adapted strains: MACo3 from Montagutelli *et al* (preprint: Montagutelli *et al*, 2021a), WBP-1 from Huang *et al* (2021), MASCp36 from Sun *et al* (2021), HRB26M, which also contains a deletion near the furin site, from Wang *et al* (2020) and MA10 from Leist *et al* (2020). Other changes outside of the RBD were also noted in mouse-adapted SARS-CoV-2 genomes.

TB *et al* (2021) Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020.

Eurosurveillance 26: 2100009

Leist SR, Dinnon KH, Schäfer A, Tse LV, Okuda K, Hou YJ, West A, Edwards CE, Sanders W, Fritch EJ *et al* (2020) A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. *Cell* 183: 1070–1085

Montagutelli X, Prot M, Jouvion G, Levillayer L, Conquet L, Reyes-Gomez E, Donati F, Albert M, van der Werf S, Jaubert J *et al* (2021a) A mouse-adapted SARS-CoV-2 strain replicating

in standard laboratory mice. *bioRxiv*
https://doi.org/10.1101/2021.07.10.451880
[PREPRINT]

Montagutelli X, Prot M, Levillayer L, Salazar EB, Jouvion G, Conquet L, Donati F, Albert M, Gambaro F, Behillil S *et al* (2021b) The B1.351 and P.1 variants extend SARS-CoV-2 host range to mice. *bioRxiv* https://doi.org/10.1101/2021.03.18.436013 [PREPRINT]

OIE (2022) (World Organization for Animal Health) COVID-19 events in animals. https://www.oie.int/en/what-we-offer/emergency-and-resilience/covid-19/#ui-id-3

Sun S, Gu H, Cao L, Chen QI, Ye Q, Yang G, Li R-T, Fan H, Deng Y-Q, Song X *et al* (2021) Characterization

and structural basis of a lethal mouse-adapted SARS-CoV-2. *Nat Commun* 12: 5654

Wang J, Shuai L, Wang C, Liu R, He X, Zhang X, Sun Z, Shan D, Ge J, Wang X *et al* (2020) Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice. *Protein Cell* 11: 776–782

<figure><img src="image_5.png" /></figure>

**License:** This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.